Chicago – October 10, 2014 – Mesothelioma Treatments Conference

For lawyers and others, on Friday October 10, 2014, there is a Chicago area opportunity to learn more about the genomics of mesothelioma, and traditional and new treatments. The speakers include some very knowledgeable and dedicated researchers and treating physicians. The opportunity arises through the “Chicago Regional Conference on Malignant Mesothelioma, [which] is a one-day event geared to patients and family members, covering a variety of topics related to mesothelioma and presented by local and regional area experts. The conference [at the Palmer House,] is a collaborative effort between the Mesothelioma Applied Research Foundation and The University of Chicago Medicine. “ Register at the web site – here. The fee is a bargain – $25. Set out below is further information from the MARF web site.

Mary Hesdorrfer and others have guided MARF away from it’s past, partisan days. In my view, it’s a very fine organization, and so my contributions to asbestos research go through MARF.

CONFERENCE CHAIRS Mary Hesdorffer, MS, APRN-BC, is a nurse practitioner with over 16 years of experience in mesothelioma treatment. She is an expert in clinical trials for mesothelioma and her work has been published in a variety of scientific journals. Ms. Hesdorffer serves as the executive director of the Mesothelioma Applied Research Foundation.

Hedy Lee Kindler, MD, Professor of Medicine at the University of Chicago, is the Director of the mesothelioma and Gastrointestinal Oncology Programs at the University of Chicago Medicine. Dr. Kindler is an internationally recognized cancer expert who specializes in the medical management of pleural and peritoneal mesothelioma. Her research focuses on the investigation of novel agents for mesothelioma, and she designs and leads many innovative clinical trials for this disease.”

The agenda is pasted below:

Melinda Kotzian, CEO of the Meso Foundation 9:40 – 10:10 Empowering the patient and their loved ones Mary Hesdorffer, MS, APRN-BC, ED, of the Meso Foundation 10:10 – 10:40 What’s in that picture? Mesothelioma imaging demystified Samuel Armato, III, PhD, and Christopher Straus, MD, of the University of Chicago 10:40 – 10:50 Break 10:50 – 11:10 The genetics of mesothelioma Jane E. Churpek, MD, and Olufunmilayo I. Olopade, MD, FACP of the University of Chicago 11:10 – 11:30 Cancer stem cells: Targeting the Achilles’ heel of mesothelioma Faris Farassati, PhD, PharmD, of the University of Kansas Hospital 11:30 – 11:50 Immune checkpoint blockade in mesothelioma Tanguy Seiwert, MD, of the University of Chicago 11:50 – 12:20 Q & A 12:30 – 1:30 Lunch 1:30 – 1:50 Systemic therapies for mesothelioma: Standard treatments and clinical trials Hedy Lee Kindler, MD, of the University of Chicago 1:50 – 2:05 A novel approach: The measles vaccine for mesothelioma 2:05 – 2:55 Innovative new therapies for mesothelioma: Panel discussion and Q & A Hedy Lee Kindler, MD, of the University of Chicago, and James Stevenson, MD, of the Cleveland Clinic. Moderated by Lee M. Krug, MD, of Memorial Sloan Kettering Cancer Center. 2:55 – 3:15 Peritoneal mesothelioma: Surgery and intraperitoneal H. Richard Alexander, MD, of the University of Maryland Medical Center

0 views

Recent Posts

See All

About Kirk

Since becoming a lawyer in 1983, Kirk’s over 30 years of practice have focused on advising a wide range of corporations, associations, and individuals (as both plaintiffs and defendants) on both tort and commercial law issues centered around “mass torts.”

Read More...

Copyright © 2020, GlobalTort All Rights Reserved.